Cargando…
Performance of the PRO-C3 collagen neo-epitope biomarker in non-alcoholic fatty liver disease
There is an unmet need for non-invasive biomarkers in non-alcoholic fatty liver disease (NAFLD) that can diagnose advanced disease and identify patients suitable for clinical trials. The PRO-C3 collagen neo-epitope is a putative direct marker of fibrogenesis. We assessed the performance of PRO-C3 in...
Autores principales: | Boyle, Marie, Tiniakos, Dina, Schattenberg, Jorn M., Ratziu, Vlad, Bugianessi, Elisabetta, Petta, Salvatore, Oliveira, Claudia P., Govaere, Olivier, Younes, Ramy, McPherson, Stuart, Bedossa, Pierre, Nielsen, Mette J, Karsdal, Morten, Leeming, Diana, Kendrick, Stuart, Anstee, Quentin M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7001575/ https://www.ncbi.nlm.nih.gov/pubmed/32039369 http://dx.doi.org/10.1016/j.jhepr.2019.06.004 |
Ejemplares similares
-
A proteo-transcriptomic map of non-alcoholic fatty liver disease signatures
por: Govaere, Olivier, et al.
Publicado: (2023) -
Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis
por: McPherson, Stuart, et al.
Publicado: (2017) -
Increased serum miR-193a-5p during non-alcoholic fatty liver disease progression: Diagnostic and mechanistic relevance
por: Johnson, Katherine, et al.
Publicado: (2021) -
Novel serological neo-epitope markers of extracellular matrix proteins for the detection of portal hypertension
por: Leeming, D J, et al.
Publicado: (2013) -
Metabolic signatures across the full spectrum of non-alcoholic fatty liver disease
por: McGlinchey, Aidan J., et al.
Publicado: (2022)